TrademarkDir
DNDI DRUGS FOR NEGLECTED DISEASES INITIATIVE
LIVE

Serial Number

79052987

Owner

Drugs for Neglected Diseases initiative; (DNDi)

Attorney

Glenn A. Gundersen

Filing Date

Apr 25, 2008

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DNDI DRUGS FOR NEGLECTED DISEASES INITIATIVE Trademark

Serial Number: 79052987 • Registration: 3602765

DNDI DRUGS FOR NEGLECTED DISEASES INITIATIVE is a trademark filed by Drugs for Neglected Diseases initiative; (DNDi) on April 25, 2008. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Drugs for Neglected Diseases initiative; (DNDi)

Place Saint-Gervais 1

Entity Type: 12

Drugs for Neglected Diseases initiative (3 trademarks)

Chemin Camille-Vidart 15

Entity Type: 12

Trademark Details

Filing Date

April 25, 2008

Registration Date

April 7, 2009

Published for Opposition

January 20, 2009

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 3, 2021 ADCH
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 1, 2019 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Sep 12, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 12, 2019 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 2, 2019 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 2, 2019 NA71
REGISTERED-SEC.71 ACCEPTED
Jan 2, 2019 71AG
TEAS SECTION 71 RECEIVED
Dec 4, 2018 ES71
INTERNATIONAL REGISTRATION RENEWED
May 17, 2018 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Apr 7, 2018 REM4
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 7, 2015 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 7, 2015 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 6, 2015 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 27, 2015 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 7, 2013 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 14, 2011 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2009 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2009 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 8, 2009 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2009 R.PR
PUBLISHED FOR OPPOSITION
Jan 20, 2009 PUBO
NOTICE OF PUBLICATION
Dec 31, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 17, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Dec 2, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2008 CRFA
PAPER RECEIVED
Nov 26, 2008 MAIL
FAX RECEIVED
Nov 20, 2008 FAXX
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Nov 3, 2008 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Oct 31, 2008 NAUD
AMENDMENT FROM APPLICANT ENTERED
Oct 17, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2008 CRFA
ASSIGNED TO LIE
Oct 16, 2008 ALIE
PAPER RECEIVED
Sep 30, 2008 MAIL
REFUSAL PROCESSED BY IB
Sep 4, 2008 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2008 RFCS
REFUSAL PROCESSED BY MPU
Aug 19, 2008 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 19, 2008 RFCR
NON-FINAL ACTION WRITTEN
Aug 18, 2008 CNRT
ASSIGNED TO EXAMINER
Aug 11, 2008 DOCK
NEW APPLICATION ENTERED
May 30, 2008 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 29, 2008 REPR

Related Trademarks

More from this Owner

DNDI BEST SCIENCE FOR THE MOST NEGLECTED logo

DNDI BEST SCIENCE FOR THE MOST NEGLECTED

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP logo

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP logo

GARDP GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP